3 research outputs found

    Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients

    No full text
    International audienceCancer patients are considered highly vulnerable to the COVID-19 pandemic. However, delaying cancer-specific therapies could have a deleterious effect on survival. The potential suppressive effects of chemotherapies or cancer-related microenvironment raised the question on how cancer patients' immune system responds to SARS-CoV-2 virus
    corecore